Sanofi Gets Positive Response from FDA Panel

An FDA advisory panel has recommended that the agency approve Sanofi-Pasteur’s (Lyon, France, www.sanofipasteur.com) H5N1 bird flu vaccine. The panel voted 13­–0 with one abstention. The vaccines and related biological products advisory committee agreed on February 27, 2007, that the data were sufficient to support the vaccine’s effectiveness during a pandemic.